Following participation in these educational activities, you will be able to:
- Discuss the importance of timely treatment of type 2 diabetes and its impact on patient health and outcomes.
- Compare the efficacy and safety profiles of once weekly GLP-1RAs.
- Explain the next generation of GLP-1RAs including the mode of absorption, mechanism of action, dosing schedule, pharmacokinetic/pharmacodynamic properties, glycemic/weight loss efficacy and safety.
These learning activities are suitable for, but not limited to, diabetes specialists, primary care physicians, specialist diabetes nurses, cardiologists, and all other healthcare professionals interested in the treatment of type 2 diabetes.
An application has been made to the UEMS EACCME® for CME accreditation of the English version of the webcast.
This program is made possible thanks to an independent educational grant from Novo Nordisk A/S.
Springer Healthcare IME
The Campus, 4 Crinan Street
London, N1 9XW, UK